NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

GH

Guardant Health Inc

Jul 09 • 11:33AM ET

50.63

Dollar change -0.19
Percentage change -0.37	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN QGEN EXAS FLGT BIO SRPT MYGN NTRA CDNA TXG

| Held by: VTI IWM VB VXF ARKK VBK ARKG IWO SCHA CGGR

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.38	Insider Own	4.95%	Shs Outstand	123.65M	Perf Week	-0.16%
Market Cap	6.27B	Forward P/E	-	EPS next Y	-2.35	Insider Trans	-5.61%	Shs Float	117.75M	Perf Month	5.35%
Enterprise Value	6.88B	PEG	-	EPS next Q	-0.72	Inst Own	96.53%	Short Float	8.49%	Perf Quarter	21.18%
Income	-416.55M	P/S	8.10	EPS this Y	22.70%	Inst Trans	0.20%	Short Ratio	4.36	Perf Half Y	49.97%
Sales	774.00M	P/B	-	EPS next Y	14.74%	ROA	-27.33%	Short Interest	10.00M	Perf YTD	65.73%
Book/sh	-2.03	P/C	8.98	EPS next 5Y	21.07%	ROE	-4584.47%	52W High	53.42 -5.22%	Perf Year	76.10%
Cash/sh	5.64	P/FCF	-	EPS past 3/5Y	3.89% -33.61%	ROIC	-40.60%	52W Low	20.14 151.39%	Perf 3Y	25.51%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	25.52% 28.08%	Gross Margin	61.34%	Volatility	3.87% 4.59%	Perf 5Y	-37.59%
Dividend TTM	-	EV/Sales	8.89	EPS Y/Y TTM	13.87%	Oper. Margin	-58.78%	ATR (14)	2.25	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.76	Sales Y/Y TTM	28.20%	Profit Margin	-53.82%	RSI (14)	59.32	Recom	1.54
Dividend Gr. 3/5Y	- -	Current Ratio	4.11	EPS Q/Q	18.68%	SMA20	1.29%	Beta	1.46	Target Price	58.95
Payout	-	Debt/Eq	-	Sales Q/Q	20.76%	SMA50	10.80%	Rel Volume	0.44	Prev Close	50.82
Employees	2021	LT Debt/Eq	-	Earnings	Apr 30 AMC	SMA200	32.40%	Avg Volume	2.29M	Price	50.63
IPO	Oct 04, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-1.28% 7.03%	Trades		Volume	350,901	Change	-0.37%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-10-25	Initiated	Mizuho	Outperform	$55
Jan-23-25	Initiated	Barclays	Overweight	$60
Jun-28-24	Upgrade	Guggenheim	Neutral → Buy	$36
Jun-03-24	Resumed	Jefferies	Buy	$32
Apr-24-24	Resumed	Craig Hallum	Buy	$28
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-13-23	Upgrade	Raymond James	Mkt Perform → Outperform	$27
Sep-28-23	Initiated	Bernstein	Outperform	$34
Sep-27-23	Upgrade	Piper Sandler	Neutral → Overweight	$40
Jul-05-23	Resumed	JP Morgan	Overweight	$65
May-26-23	Upgrade	Citigroup	Neutral → Buy	$28 → $40
May-05-23	Initiated	UBS	Buy	$40
Mar-09-23	Downgrade	Citigroup	Buy → Neutral	$60 → $33
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$36
Nov-01-22	Downgrade	Piper Sandler	Overweight → Neutral	$65 → $50
Oct-19-22	Initiated	Craig Hallum	Buy	$88
Oct-06-22	Initiated	Stephens	Overweight	$99
Aug-25-22	Initiated	Credit Suisse	Outperform	$80
Jun-03-22	Initiated	Piper Sandler	Overweight	$65

Show Previous Ratings

Jul-04-25 08:43AM	Tempus AI Revenues & Profit Rise: What to Expect Ahead of Q2 Release (Zacks)
Jun-30-25 07:26AM	The 5 Most Interesting Analyst Questions From Guardant Health's Q1 Earnings Call (StockStory)
Jun-25-25 08:51AM	The Top 5 Analyst Questions From Guardant Health's Q1 Earnings Call (StockStory)
Jun-23-25 03:00PM	TEM vs. GH: Which AI in Precision Oncology Stock Has More Upside Now? (Zacks)
12:07PM	Medical Services Name Flirts With A Buy Point (Investor's Business Daily)
08:41AM	Loading…
Jun-20-25 08:41AM	Tempus AI's 89% Genomics Surge: Will the Momentum Keep Building? (Zacks)
Jun-19-25 05:54PM	How Will Dow Jones Futures Open As Trump Says 'Two Weeks' For Iran Decision? (Investor's Business Daily)
03:35PM	Will Dow Jones Futures Rebound As Trump Says 'Two Weeks' For Iran Decision? (Investor's Business Daily)
Jun-13-25 12:35AM	3 of Wall Street's Favorite Stocks Facing Headwinds (StockStory)
Jun-10-25 07:05AM	Guardant Health Wins Fast Company's 2025 World Changing Ideas Award for Shield Blood Test for Colorectal Cancer Screening (Business Wire)
Jun-09-25 08:05AM	New Study Published in ESMO Open Highlights Guardant Reveal's Performance in Detecting Minimal Residual Disease in Patients with Early-Stage Breast Cancer (Business Wire)
Jun-06-25 09:09AM	Tempus AI Eyes Positive Adjusted EBITDA in 2025: Is It Taking Shape? (Zacks)
Jun-04-25 09:45AM	Guardant Healths MCD test earns FDA breakthrough designation (Medical Device Network)
Jun-03-25 05:48PM	Why Guardant Health Stock Surged Nearly 9% Higher Today (Motley Fool) +8.76%
08:05AM	FDA Grants Breakthrough Device Designation to Guardant Health's Shield Multi-Cancer Detection (MCD) Test (Business Wire)
08:05AM	Loading…
Jun-02-25 08:05AM	National Comprehensive Cancer Network (NCCN) Updates Colorectal Cancer Screening Guidelines to Include Shield Blood-Based Screening (Business Wire)
07:00AM	SERENA-6 Phase III Trial Demonstrates Clinical Value of Guardant360 CDx Test to Detect Emergence of Endocrine Resistance and Inform a Switch in Therapy Before Radiological Disease Progression in Advanced Breast Cancer (Business Wire)
May-31-25 08:05AM	In Largest Molecular Residual Disease (MRD) Study in Colon Cancer, Guardant Reveal Testing Prior to Chemotherapy Provides Robust Stratification for Risk of Disease Recurrence and Survival to Enable Timely Treatment Decisions (Business Wire)
May-28-25 11:39PM	Guardant Health, Inc. (GH) Expands Liquid Biopsy to Pinpoint Tumor Origins and Biomarkers (Insider Monkey)
May-27-25 11:38PM	Firing on All Cylinders: Guardant Health (NASDAQ:GH) Q1 Earnings Lead the Way (StockStory)
05:30PM	Guardant Health Introduces Nearly a Dozen Groundbreaking Smart Liquid Biopsy Applications for Guardant360 Liquid Test (Business Wire)
May-23-25 10:00AM	New Tests Promise to Reveal the Secrets in Your Blood (The Wall Street Journal)
May-22-25 05:05PM	Guardant Health and Collaborators to Present Over 19 Studies Demonstrating Role of Liquid Biopsy in Advancing Precision Oncology at 2025 ASCO Annual Meeting (Business Wire)
May-21-25 04:58PM	Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know (StockStory) -7.21%
04:33PM	Guardant Health (GH) introduces IHC Solid Tumor Testing to its Portfolio (Insider Monkey)
08:05AM	Guardant Health Introduces Comprehensive Immunohistochemistry Testing for Solid Tumors (Business Wire)
May-20-25 08:05AM	Guardant Health Introduces Hereditary Cancer Testing to Identify Inherited Predispositions to Certain Types of Cancer (Business Wire)
May-16-25 07:30PM	Guardant Health: A Promising Player in the Liquid Biopsy Market (Motley Fool)
May-14-25 06:20AM	Is First Trust Mid Cap Growth AlphaDEX ETF (FNY) a Strong ETF Right Now? (Zacks)
May-08-25 04:05PM	Guardant Health to Participate in Upcoming Investor Conferences (Business Wire)
09:20AM	Loading…
09:20AM	TIME Names Guardant Health Co-CEOs to 2025 TIME100 Health List of the 100 Most Influential People in Global Health This Year (Business Wire)
May-07-25 05:05PM	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -5.22%
May-01-25 04:33PM	Guardant Health: Tailwinds Are Beginning To Impact The Financials (Seeking Alpha)
12:52PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
12:04PM	Q1 2025 Guardant Health Inc Earnings Call (Thomson Reuters StreetEvents)
03:18AM	Guardant Health Inc (GH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Apr-30-25 10:25PM	Guardant Health, Inc. (GH) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:50PM	Guardant Health (GH) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:50PM	Guardant Health's (NASDAQ:GH) Q1: Strong Sales, Stock Soars (StockStory)
04:47PM	Guardant Health: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Guardant Health Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance (Business Wire)
Apr-29-25 04:20PM	Guardant Health Presents Data Demonstrating Strong Performance of Shield Multi-Cancer Detection Test Across 10 Tumor Types (Business Wire)
08:45AM	Repligen (RGEN) Tops Q1 Earnings and Revenue Estimates (Zacks)
03:06AM	Guardant Health (GH) Q1 Earnings Report Preview: What To Look For (StockStory)
Apr-28-25 09:12AM	CORRECTING and REPLACING Guardant Health Launches Guardant360 Tissue, First Tissue Molecular Profiling Test with Comprehensive Multiomic Analysis to Provide a More Complete View of Cancer (Business Wire)
08:05AM	Guardant Health Launches Guardant360 Tissue, First Tissue Molecular Profiling Test with Comprehensive Multiomic Analysis to Provide a More Complete View of Cancer (Business Wire)
Apr-24-25 03:36PM	Guardant Health, Pfizer Collaborate To Develop New Cancer Therapies Using Liquid Biopsy Platform (Benzinga)
10:01AM	Amgen (AMGN) Earnings Expected to Grow: Should You Buy? (Zacks)
09:45AM	Aristotle Focus Growth Q1 2025 Commentary (Seeking Alpha)
08:05AM	Guardant Health Announces Strategic Collaboration With Pfizer to Support Development and Commercialization of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform (Business Wire)
Apr-23-25 06:06PM	BBSC: Lagging Several Small-Cap Core ETFs (Seeking Alpha)
10:01AM	Earnings Preview: Guardant Health (GH) Q1 Earnings Expected to Decline (Zacks)
Apr-22-25 10:48AM	Guardant Health (GH) Rose Following Several Positive News Reports (Insider Monkey)
08:05AM	Guardant Health to Present Data Highlighting Advances in Multi-Cancer Detection and Liquid and Tissue Molecular Profiling at AACR (Business Wire)
Apr-21-25 05:01AM	3 Reasons to Sell GH and 1 Stock to Buy Instead (StockStory) -5.25%
Apr-17-25 04:15PM	The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It. (Investor's Business Daily)
Apr-15-25 10:05AM	Guardant Health price target raised to $60 from $56 at BofA (TipRanks)
Apr-14-25 10:51PM	Aristotle Atlantic's Core Equity Q1 2025 Commentary (Seeking Alpha)
02:09PM	Aristotle Large Cap Growth Q1 2025 Commentary (Seeking Alpha)
Apr-10-25 04:05PM	Guardant Health to Report First Quarter 2025 Financial Results on April 30, 2025 (Business Wire) -6.22% +6.25%
Apr-08-25 05:01AM	Reflecting On Testing & Diagnostics Services Stocks' Q4 Earnings: Guardant Health (NASDAQ:GH) (StockStory)
Apr-03-25 08:05AM	Guardant Health and Bayshore HealthCare Partner to Expand Access to Advanced Precision Oncology Testing in Canada (Business Wire)
Apr-01-25 08:50AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
Mar-30-25 03:25AM	abrdn Healthcare Opportunities Fund Q4 2024 Commentary (Seeking Alpha)
Mar-29-25 07:15AM	4 Healthcare Stocks With Massive Gains-and More to Come (MarketBeat)
Mar-25-25 04:05PM	Guardant Healths Shield Blood Test Now Covered for VA Community Care Beneficiaries (Business Wire)
Mar-21-25 04:21PM	These Seven Risky Bets Take The Shine Off Gold; One Looks To Extend 46% Gain (Investor's Business Daily)
Mar-20-25 09:05AM	Invesco Health Care Fund Q4 2024 Commentary (SeekingAlpha)
Mar-11-25 06:46PM	Analyst Report: Guardant Health, Inc. (Morningstar Research) +18.95%
07:00AM	Guardant Health Receives ADLT Status From CMS for Shield Blood Test (Business Wire)
Mar-10-25 07:12PM	Analyst Report: Guardant Health, Inc. (Morningstar Research) -8.85%
Mar-05-25 08:05AM	Guardant Health Joins Forces With Dak Prescott's Faith Fight Finish Foundation and Feist-Weiller Cancer Center's Partners in Wellness to Boost Colon Cancer Screening in Underserved Communities (Business Wire)
Mar-03-25 02:49PM	Guardant Healths (NASDAQ:GH) Q4: Beats On Revenue (StockStory)
Feb-28-25 05:05PM	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-27-25 08:05AM	New Guardant Health/Harris Poll Survey Highlights Patient Fear and Anxiety as Major Barriers to Colorectal Cancer Screening, but Blood Test Option Offers Hope for Change (Business Wire)
Feb-26-25 11:53AM	Guardant Health (GH): Among the Best Performing Mid Cap Stocks to Buy According to Analysts (Insider Monkey) +7.04%
Feb-25-25 09:40AM	Is Guardant Health (GH) Outperforming Other Medical Stocks This Year? (Zacks)
Feb-24-25 06:00AM	Guardant accuses Natera of poaching employees, stealing trade secrets (MedTech Dive)
Feb-22-25 09:20AM	Guardant Health price target raised to $56 from $42 at TD Cowen (TipRanks)
Feb-21-25 04:58PM	These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50 (Investor's Business Daily) -9.56%
01:33PM	What's Going On With Cancer Diagnostic Firm Guardant Health On Friday? (Benzinga)
10:13AM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
02:15AM	Guardant Health Inc (GH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Feb-20-25 06:30PM	Guardant Health (GH) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:40PM	Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:54PM	Guardant Health: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Guardant Health Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook (Business Wire)
Feb-19-25 02:43PM	Why Guardant Health, Inc. (GH) is the Best Performing Healthcare Stock So Far in 2025 (Insider Monkey)
Feb-17-25 09:16AM	Exploring Analyst Estimates for Guardant Health (GH) Q4 Earnings, Beyond Revenue and EPS (Zacks)
Feb-13-25 10:00AM	Guardant Health (GH) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Feb-11-25 09:55AM	Here's Why Guardant Health (GH) Is a Great 'Buy the Bottom' Stock Now (Zacks)
Feb-10-25 07:00AM	Guardant Health to Participate in Upcoming Investor Conferences (Business Wire)
Feb-07-25 06:30AM	Guardant Health Announces Debt Exchange Transactions (Business Wire)
Feb-06-25 09:40AM	Are Medical Stocks Lagging Guardant Health (GH) This Year? (Zacks)
Feb-02-25 04:27PM	Why Guardant Health, Inc. (GH) Is Among the Best Booming Stocks to Invest in Now? (Insider Monkey)
Jan-30-25 04:05PM	Guardant Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025 (Business Wire) -5.93%
08:05AM	Guardant Healths Shield Test Selected by Abu Dhabi Department of Health for Blood-Based Colorectal Cancer Screening Program (Business Wire)
Jan-26-25 03:22AM	Why Guardant Health (GH) Is Skyrocketing Now (Insider Monkey)
Jan-23-25 08:05AM	Guardant Health to Present Data at ASCO GI Demonstrating the Value of Its Precision Oncology Tools for Cancer Detection, Treatment Decisions and Therapy Development (Business Wire)
Jan-22-25 12:04PM	Why Guardant Health, Inc. (GH) Soared At The Start Of The Trading Week (Insider Monkey)

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Joyce Meghan V.	Director	Jul 04 '25	Option Exercise	0.00	66	0	11,216	Jul 07 04:44 PM
Saia John G.	Chief Legal Officer	Jul 01 '25	Option Exercise	0.00	2,641	0	46,209	Jul 02 09:26 PM
Kalia Kumud	Chief Information Officer	Jul 01 '25	Option Exercise	0.00	2,691	0	21,865	Jul 02 09:25 PM
Freeman Chris	Chief Commercial Officer	Jul 01 '25	Option Exercise	0.00	3,596	0	50,353	Jul 02 09:24 PM
EAGLE CRAIG	Chief Medical Officer	Jul 01 '25	Option Exercise	0.00	3,381	0	38,505	Jul 02 09:22 PM
Chudova Darya	Chief Technology Officer	Jul 01 '25	Option Exercise	0.00	3,007	0	82,819	Jul 02 09:21 PM
Bell Michael Brian	Chief Financial Officer	Jul 01 '25	Option Exercise	0.00	2,084	0	44,085	Jul 02 09:20 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jun 30 '25	Option Exercise	0.00	4,815	0	2,074,271	Jul 02 09:18 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jul 01 '25	Option Exercise	0.00	23,997	0	1,995,827	Jul 02 09:18 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jul 01 '25	Sale	50.88	100,000	5,087,630	1,971,830	Jul 02 09:18 PM
Krognes Steve E.	Director	Jun 30 '25	Option Exercise	0.00	154	0	17,819	Jul 02 09:17 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Jun 30 '25	Option Exercise	0.00	4,815	0	2,414,105	Jul 02 09:16 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Jul 01 '25	Option Exercise	0.00	23,997	0	2,435,661	Jul 02 09:16 PM
Tariq Musa	Director	Jun 18 '25	Sale	49.47	3,213	158,947	7,190	Jun 20 05:42 PM
POTTER MYRTLE S	Director	Jun 18 '25	Sale	49.47	26	1,286	18,154	Jun 20 05:40 PM
CLARK IAN T	Director	Jun 17 '25	Sale	48.38	6,672	322,819	9,851	Jun 20 05:26 PM
POTTER MYRTLE S	Director	Jun 18 '25	Proposed Sale	49.46	26	1,286		Jun 18 05:00 PM
Tariq Musa	Director	Jun 18 '25	Proposed Sale	49.47	3,213	158,947		Jun 18 04:43 PM
CLARK IAN T	Director	Jun 17 '25	Proposed Sale	48.38	6,672	322,818		Jun 17 04:01 PM
Saia John G.	Chief Legal Officer	Jun 15 '25	Option Exercise	0.00	1,020	0	44,103	Jun 16 08:05 PM
Kalia Kumud	Chief Information Officer	Jun 15 '25	Option Exercise	0.00	637	0	19,402	Jun 16 08:04 PM
Freeman Chris	Chief Commercial Officer	Jun 15 '25	Option Exercise	0.00	6,281	0	49,432	Jun 16 08:03 PM
EAGLE CRAIG	Chief Medical Officer	Jun 15 '25	Option Exercise	0.00	1,402	0	35,835	Jun 16 08:01 PM
Bell Michael Brian	Chief Financial Officer	Jun 15 '25	Option Exercise	0.00	3,272	0	43,660	Jun 16 07:59 PM
POTTER MYRTLE S	Director	Jun 12 '25	Option Exercise	0.00	6,674	0	20,737	Jun 16 07:28 PM
POTTER MYRTLE S	Director	Jun 15 '25	Option Exercise	0.00	69	0	20,806	Jun 16 07:28 PM
POTTER MYRTLE S	Director	Jun 16 '25	Sale	49.70	2,626	130,512	18,180	Jun 16 07:28 PM
Joyce Meghan V.	Director	Jun 12 '25	Option Exercise	0.00	6,674	0	14,487	Jun 16 07:27 PM
Joyce Meghan V.	Director	Jun 13 '25	Sale	47.22	3,337	157,573	11,150	Jun 16 07:27 PM
Tariq Musa	Director	Jun 12 '25	Option Exercise	0.00	6,674	0	10,153	Jun 16 07:25 PM
Tariq Musa	Director	Jun 15 '25	Option Exercise	0.00	250	0	10,403	Jun 16 07:25 PM
Krognes Steve E.	Director	Jun 12 '25	Option Exercise	0.00	6,674	0	17,665	Jun 16 07:24 PM
Gadde Vijaya	Director	Jun 12 '25	Option Exercise	0.00	6,674	0	24,314	Jun 16 07:23 PM
CLARK IAN T	Director	Jun 12 '25	Option Exercise	0.00	8,088	0	16,523	Jun 16 07:21 PM
POTTER MYRTLE S	Director	Jun 16 '25	Proposed Sale	49.70	2,626	130,512		Jun 16 04:20 PM
Joyce Meghan V.	Director	Jun 13 '25	Proposed Sale	47.22	3,337	157,573		Jun 13 04:03 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jun 09 '25	Sale	50.09	77,853	3,899,937	2,069,456	Jun 09 09:45 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jun 06 '25	Sale	50.07	39,751	1,990,420	2,147,309	Jun 09 09:45 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jun 05 '25	Sale	50.00	1,680	84,007	2,187,060	Jun 09 09:45 PM
Joyce Meghan V.	Director	Jun 04 '25	Option Exercise	0.00	67	0	7,813	Jun 05 07:14 PM
Kalia Kumud	Chief Information Officer	Jun 03 '25	Sale	46.39	4,000	185,562	18,765	Jun 05 07:00 PM
Joyce Meghan V.	Director	Jun 02 '25	Sale	41.66	100	4,166	7,746	Jun 03 05:49 PM
Kalia Kumud	Officer	Jun 03 '25	Proposed Sale	46.39	4,000	185,562		Jun 03 04:33 PM
Saia John G.	Chief Legal Officer	Jun 01 '25	Option Exercise	0.00	263	0	43,221	Jun 02 06:05 PM
Kalia Kumud	Chief Information Officer	Jun 01 '25	Option Exercise	0.00	710	0	23,019	Jun 02 06:04 PM
Chudova Darya	Chief Technology Officer	Jun 01 '25	Option Exercise	0.00	316	0	79,973	Jun 02 06:03 PM
Krognes Steve E.	Director	May 31 '25	Option Exercise	0.00	154	0	10,991	Jun 02 06:01 PM
Joyce Meghan V.	Director	Jun 02 '25	Proposed Sale	41.66	100	4,166		Jun 02 04:05 PM
Tariq Musa	Director	May 19 '25	Sale	40.04	116	4,645	3,479	May 20 04:57 PM
Tariq Musa	Director	May 15 '25	Option Exercise	0.00	250	0	3,595	May 19 07:12 PM
POTTER MYRTLE S	Director	May 15 '25	Option Exercise	0.00	68	0	14,063	May 19 07:11 PM
EAGLE CRAIG	Chief Medical Officer	May 15 '25	Option Exercise	0.00	3,718	0	36,318	May 19 07:09 PM
Chudova Darya	Chief Technology Officer	May 15 '25	Option Exercise	0.00	8,705	0	83,210	May 19 07:08 PM
Tariq Musa	Director	May 19 '25	Proposed Sale	40.04	116	4,645		May 19 04:04 PM
Joyce Meghan V.	Director	May 04 '25	Option Exercise	0.00	66	0	7,846	May 05 09:03 PM
Talasaz AmirAli	Co-Chief Executive Officer	May 01 '25	Sale	49.01	106,784	5,233,421	2,202,672	May 05 09:02 PM
Talasaz AmirAli	Co-Chief Executive Officer	May 02 '25	Sale	50.47	13,932	703,151	2,188,740	May 05 09:02 PM
Krognes Steve E.	Director	Apr 30 '25	Option Exercise	0.00	155	0	10,837	May 01 04:56 PM
Talasaz AmirAli	Officer	May 01 '25	Proposed Sale	49.01	340,000	16,663,196		May 01 04:56 PM
Tariq Musa	Director	Apr 17 '25	Sale	44.79	116	5,196	3,345	Apr 18 01:35 PM
Tariq Musa	Director	Apr 17 '25	Proposed Sale	44.79	116	5,196		Apr 17 04:02 PM
Tariq Musa	Director	Apr 15 '25	Option Exercise	0.00	250	0	3,461	Apr 16 04:46 PM
Saia John G.	Chief Legal Officer	Apr 15 '25	Option Exercise	0.00	7,568	0	46,914	Apr 16 04:45 PM
POTTER MYRTLE S	Director	Apr 15 '25	Option Exercise	0.00	68	0	13,995	Apr 16 04:43 PM
Joyce Meghan V.	Director	Apr 04 '25	Option Exercise	0.00	66	0	7,780	Apr 07 05:31 PM
Saia John G.	Chief Legal Officer	Apr 01 '25	Option Exercise	0.00	2,641	0	40,706	Apr 02 05:38 PM
Kalia Kumud	Chief Information Officer	Apr 01 '25	Option Exercise	0.00	2,691	0	22,411	Apr 02 05:36 PM
Freeman Chris	Chief Commercial Officer	Apr 01 '25	Option Exercise	0.00	3,595	0	43,398	Apr 02 05:35 PM
EAGLE CRAIG	Chief Medical Officer	Apr 01 '25	Option Exercise	0.00	3,381	0	33,895	Apr 02 05:33 PM
Chudova Darya	Chief Technology Officer	Apr 01 '25	Option Exercise	0.00	3,006	0	76,029	Apr 02 05:32 PM
Bell Michael Brian	Chief Financial Officer	Apr 01 '25	Option Exercise	0.00	2,084	0	41,445	Apr 02 05:29 PM
Krognes Steve E.	Director	Mar 31 '25	Option Exercise	0.00	154	0	10,682	Apr 02 05:27 PM
Talasaz AmirAli	Co-Chief Executive Officer	Mar 31 '25	Option Exercise	0.00	4,814	0	2,300,061	Apr 02 05:26 PM
Talasaz AmirAli	Co-Chief Executive Officer	Apr 01 '25	Option Exercise	0.00	23,998	0	2,321,619	Apr 02 05:26 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Mar 31 '25	Option Exercise	0.00	4,814	0	2,399,895	Apr 02 05:24 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Apr 01 '25	Option Exercise	0.00	23,998	0	2,421,453	Apr 02 05:24 PM
Tariq Musa	Director	Mar 19 '25	Sale	43.70	116	5,069	3,211	Mar 20 05:05 PM
Tariq Musa	Director	Mar 19 '25	Proposed Sale	43.70	116	5,069		Mar 19 04:01 PM
Tariq Musa	Director	Mar 15 '25	Option Exercise	0.00	249	0	3,327	Mar 18 05:33 PM
Saia John G.	Chief Legal Officer	Mar 15 '25	Option Exercise	0.00	1,019	0	38,590	Mar 18 05:32 PM
POTTER MYRTLE S	Director	Mar 15 '25	Option Exercise	0.00	69	0	13,927	Mar 18 05:29 PM
Kalia Kumud	Chief Information Officer	Mar 15 '25	Option Exercise	0.00	637	0	23,448	Mar 18 05:27 PM
Kalia Kumud	Chief Information Officer	Mar 17 '25	Sale	43.16	3,500	151,060	19,720	Mar 18 05:27 PM
Freeman Chris	Chief Commercial Officer	Mar 15 '25	Option Exercise	0.00	1,401	0	40,190	Mar 18 05:26 PM
EAGLE CRAIG	Chief Medical Officer	Mar 15 '25	Option Exercise	0.00	1,401	0	31,014	Mar 18 05:24 PM
Bell Michael Brian	Chief Financial Officer	Mar 15 '25	Option Exercise	0.00	3,272	0	41,020	Mar 18 05:23 PM
Talasaz AmirAli	Co-Chief Executive Officer	Mar 14 '25	Option Exercise	0.00	68,769	0	2,330,100	Mar 18 05:21 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Mar 14 '25	Option Exercise	0.00	68,769	0	2,429,934	Mar 18 05:20 PM
Kalia Kumud	Officer	Mar 17 '25	Proposed Sale	43.16	3,500	151,060		Mar 17 04:24 PM
Joyce Meghan V.	Director	Mar 04 '25	Option Exercise	0.00	67	0	7,714	Mar 05 04:48 PM
Joyce Meghan V.	Director	Mar 03 '25	Sale	42.71	100	4,271	7,647	Mar 05 04:48 PM
Saia John G.	Chief Legal Officer	Mar 01 '25	Option Exercise	0.00	5,949	0	40,650	Mar 04 06:16 PM
Monroe Terilyn J.	Chief People Officer	Mar 01 '25	Option Exercise	0.00	14,894	0	26,822	Mar 04 06:15 PM
Kalia Kumud	Chief Information Officer	Mar 01 '25	Option Exercise	0.00	4,406	0	24,401	Mar 04 06:13 PM
Freeman Chris	Chief Commercial Officer	Mar 01 '25	Option Exercise	0.00	5,686	0	40,355	Mar 04 06:11 PM
EAGLE CRAIG	Chief Medical Officer	Mar 01 '25	Option Exercise	0.00	5,686	0	31,642	Mar 04 06:10 PM
Chudova Darya	Chief Technology Officer	Mar 01 '25	Option Exercise	0.00	6,001	0	76,065	Mar 04 06:08 PM
Bell Michael Brian	Chief Financial Officer	Mar 01 '25	Option Exercise	0.00	7,108	0	40,285	Mar 04 06:07 PM
Krognes Steve E.	Director	Feb 28 '25	Option Exercise	0.00	154	0	10,528	Mar 04 06:05 PM
Joyce Meghan V.	Director	Mar 03 '25	Proposed Sale	42.71	100	4,271		Mar 03 04:11 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GH

Guardant Health Inc

Upgrade your FINVIZ experience